XPH250117P37000
- 0.05
- 0.000.00%
Spdr Series Trust Spdr S&P Pharmaceuticals Etf Newsroom
Bird Flu Claims First U.S. Life in Louisiana
Market Climbed Monday Just Past Santa Rally High Water Mark | Wall Street Today
FDA Issues First Draft Guidance on Use of AI in Drug, Medical Device Development
Stock Of The Day: Will Johnson & Johnson Take The Market Lower?
Merck to Buy Vaccine Plant From WuXi Biologics: Report
CES Tech Conference Week Starts with Nvidia and Chips Climbing | Live Stock
CVS Health's Aetna Files Lawsuit Against Drugmakers For Alleged Inflated Generic Drug Prices
Citi's Recommended List of Large-cap Stocks: GOOGL, STZ, DAL, and More
BofA's Growth 10 Screen as January 2025 Trade Revs up
Healthcare Sector's 2024 Gainers and Losers: Intuitive Surgical, Boston Scientific Tops Chart
Pfizer Antiviral Paxlovid's Extended Use Shows Mixed Results for Long COVID Relief: Study
Israel Englander's Millennium Management Dumps Nvidia, Loads Up On Broadcom — Here's What The $70 Billion Hedge Fund Sees
SA Asks: Which Biotechs Are Most Likely to Be Acquired Near-term?
Novo Nordisk Seeks to Block Compounded Victoza
Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz
Friday? More Like Grinch Day | Wall Street Today
The S&P 500's 10 Worst Performing Stocks in 2023 Fell Again in 2024
Smart Money Is Betting Big In LLY Options
Viking Therapeutics Among Potential Buyout Candidates: Oppenheimer
Santa Claus Came Without Rallying the Troops | Live Stock